{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:32:44Z","timestamp":1672846364162},"reference-count":28,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.vaccine.2010.04.088","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T06:10:41Z","timestamp":1274076641000},"page":"4550-4552","source":"Crossref","is-referenced-by-count":5,"title":["Novel vaccine prime and selective BCG boost: A new tuberculosis vaccine strategy for infants of HIV-infected mothers"],"prefix":"10.1016","volume":"28","author":[{"given":"Mark","family":"Hatherill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Mahomed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2010.04.088_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.vaccine.2009.10.114","article-title":"Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen","volume":"28","author":"Skeiky","year":"2010","journal-title":"Vaccine"},{"issue":"8986","key":"10.1016\/j.vaccine.2010.04.088_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2010.04.088_bib3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"issue":"9517","key":"10.1016\/j.vaccine.2010.04.088_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.04.088_bib5","unstructured":"Global Advisory Committee on Vaccine Safety, 29\u201330 November 2006. Wkly Epidemiol Rec 2007;82(3):18\u201324."},{"key":"10.1016\/j.vaccine.2010.04.088_bib6","unstructured":"UNAIDS. Global report; 2008."},{"key":"10.1016\/j.vaccine.2010.04.088_bib7","unstructured":"DOH. National antenatal sentinel HIV & syphilis prevalence survey South Africa report; 2008."},{"issue":"7","key":"10.1016\/j.vaccine.2010.04.088_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette\u2013Guerin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.04.088_bib9","first-page":"1376","article-title":"Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants","volume":"12","author":"Hesseling","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2010.04.088_bib10","series-title":"International AIDS society conference","article-title":"Delayed complications of Bacillus Calmette\u2013Guerin (BCG) vaccination in HIV-infected children","author":"Fallo","year":"2005"},{"issue":"1","key":"10.1016\/j.vaccine.2010.04.088_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette\u2013Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.04.088_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00006454-200207000-00025","article-title":"Testing infants for human immunodeficiency virus infection","volume":"21","author":"Pugatch","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"40","key":"10.1016\/j.vaccine.2010.04.088_bib13","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.vaccine.2009.06.103","article-title":"Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response","volume":"27","author":"Kagina","year":"2009","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2010.04.088_bib14","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.04.088_bib15","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1128\/IAI.73.7.4441-4444.2005","article-title":"The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis","volume":"73","author":"Skinner","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2010.04.088_bib16","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette\u2013Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2010.04.088_bib17","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2005.12.066","article-title":"Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv","volume":"24","author":"Romano","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.04.088_bib18","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","article-title":"A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice","volume":"72","author":"Ferraz","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2010.04.088_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vaccine.2005.07.115","article-title":"Protective efficacy induced by Mycobacterium bovis bacille Calmette\u2013Guerin can be augmented in an antigen independent manner by use of non-coding plasmid DNA","volume":"24","author":"Hogarth","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.04.088_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette\u2013Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2010.04.088_bib21","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.vaccine.2010.04.088_bib22","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A Replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2010.04.088_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2010","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.04.088_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette\u2013Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.04.088_bib25","first-page":"278","article-title":"The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2010.04.088_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/ajrccm\/143.3.501","article-title":"A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire","volume":"143","author":"Braun","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"36","key":"10.1016\/j.vaccine.2010.04.088_bib27","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2007.06.045","article-title":"BCG and HIV reconsidered: moving the research agenda forward","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.04.088_bib28","first-page":"862","article-title":"HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort","volume":"13","author":"Martinson","year":"2009","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T05:27:30Z","timestamp":1544506050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10006262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":28,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0264410X10006262"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}